Craft

Entera Bio

Stock Price

$1.9

2024-10-29

Market Capitalization

$68.7 M

2024-10-29

Revenue

$42 K

FY, 2025

Entera Bio Summary

Company Summary

Overview
Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics. The Company is conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract.Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceutical ingredients). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract and are rapidly degraded by a myriad of enzymes and acids in the gastrointestinal tract.
Type
Public
Status
Active
Founded
2010
HQ
Wellesley, MA, US | view all locations
Website
http://www.enterabio.com/
Cybersecurity rating
Sectors

Key People

  • Gerald Lieberman, Chairman of the Board

    • Hillel Galitzer, COO

      • Arthur Santora, CMO

        LocationsView all

        2 locations detected

        • Wellesley, MA HQ

          United States

          37 Walnut St #300

        • Jerusalem, Jerusalem District

          Israel

        Entera Bio Financials

        Summary Financials

        Cash (Q1, 2026)
        $4.1M
        Enterprise value
        $65.5M

        Footer menu